Irish medtech company Perfuze raises €22.5m for new stroke treatment
Company developing catheter-based technology to facilitate fast clot removal
Source: irishtimes.com
Stay updated with breaking news from Medfocus Fund. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Company developing catheter-based technology to facilitate fast clot removal
Perfuze is developing catheter-based technology to remove blood clots from the brain in one pass to treat acute ischemic stroke.
Perfuze, a Galway-based medical device company developing next-generation catheter-based aspiration technology to treat large vessel occlusion acute ischemic stroke, has closed a €22.5 million Series A investment round.